Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q4 FY23 results · Jan–Mar 2023
Krishna Institute of Medical Sciences reported revenue from operations of ₹575.93 crore (up 54.7% from Q4 FY22) and net profit of ₹98.67 crore (up 18.4% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 575.93 | 372.34 | +54.7% | 562.16 | +2.4% |
| Other income | 4.88 | 8.19 | −40.3% | 6.45 | −24.3% |
| Total income | 580.81 | 380.53 | +52.6% | 568.61 | +2.1% |
| Profit before tax | 127.27 | 99.27 | +28.2% | 112.82 | +12.8% |
| Net profit for the period | 98.67 | 83.32 | +18.4% | 81.83 | +20.6% |
| Attributable to shareholders of the company | 93.27 | 80.69 | +15.6% | 76.14 | +22.5% |
| EPS, basic (₹) | 11.65 | 10.08 | +15.6% | 9.49 | +22.7% |
| Net margin (%) | 17.1 | 22.4 | 14.6 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 293.35 | 254.50 | +15.3% | 283.51 | +3.5% |
| Other income | 4.97 | 7.71 | −35.6% | 7.18 | −30.8% |
| Total income | 298.32 | 262.21 | +13.8% | 290.70 | +2.6% |
| Profit before tax | 97.97 | 84.11 | +16.5% | 85.56 | +14.5% |
| Net profit for the period | 74.70 | 63.91 | +16.9% | 64.47 | +15.9% |
| EPS, basic (₹) | 9.33 | 7.99 | +16.8% | 8.06 | +15.8% |
| Net margin (%) | 25.5 | 25.1 | 22.7 |
Consolidated
- Filed with BSE
- 19 May 2023, 14:39 IST
- Board meeting
- 18 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 19 May 2023, 14:39 IST
- Board meeting
- 18 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE